Our Services
Medical Information
Helpful Resources
Published on: 8/18/2026
It looks like the content you wanted summarized didn't come through with your message. Could you paste the text about delayed walking and metabolic causes, and I'll turn it into the summary you described?
Delayed walking in toddlers can be alarming for parents. While many children simply develop at their own pace, certain metabolic disorders may underlie significant delays. Understanding which metabolic causes to rule out can help you and your pediatrician decide on the right steps—without creating unnecessary anxiety.
Most children take their first steps between 9 and 18 months. Walking involves muscle strength, balance, coordination and intact nerve function. When a toddler isn’t cruising or taking independent steps by around 18 months, it warrants a closer look.
Metabolism refers to how the body converts food into energy and building blocks for growth. Inherited metabolic disorders—sometimes called inborn errors of metabolism—impair these pathways. As a result, a child may have:
Hypothyroidism
• What it is: Low thyroid hormone production slows growth and muscle development.
• Signs: Lethargy, constipation, dry skin, large fontanelle (soft spot).
• Testing: Serum TSH and free T4 levels.
Vitamin D Deficiency (Rickets)
• What it is: Inadequate vitamin D affects bone mineralization and muscle strength.
• Signs: Bowed legs, soft skull, delayed milestones, irritability.
• Testing: Serum 25-hydroxyvitamin D, calcium, phosphorus, alkaline phosphatase.
Phenylketonuria (PKU)
• What it is: Inability to break down phenylalanine, leading to toxic buildup.
• Signs: Developmental delays, eczema-like rash, mousty odor.
• Testing: Newborn screening heel-stick (phenylalanine level).
Mucopolysaccharidoses (MPS)
• What it is: Storage disorders causing buildup of glycosaminoglycans in tissues.
• Signs: Coarse facial features, enlarged liver/spleen, stiff joints.
• Testing: Urine glycosaminoglycan screen, enzyme assays.
Mitochondrial Disorders
• What it is: Defects in cellular energy factories (mitochondria).
• Signs: Muscle fatigue, failure to thrive, lactic acidosis.
• Testing: Lactate and pyruvate levels, genetic panels, muscle biopsy (specialist referral).
Organic Acidemias and Aminoacidopathies
• What they are: Enzyme defects in amino acid or organic acid breakdown.
• Signs: Poor feeding, vomiting, hypotonia (low muscle tone), lethargy.
• Testing: Plasma amino acids, urine organic acids.
Consider a metabolic work-up if your toddler has any combination of:
While you investigate metabolic causes, supportive therapies help your toddler build strength and skills:
It’s normal to worry. Yet many toddlers walk a bit later and have no serious underlying issue. At the same time, early identification of a metabolic disorder can make a big difference in treatment and long-term outcomes. A balanced approach:
Not sure whether your toddler’s delays need urgent evaluation? Consider a free, online symptom check, using the doctor approved Ubie Symptom Checker. It can help you decide if it’s time to see your doctor or specialist.
Some signs require prompt medical attention:
If your child shows any serious or life-threatening symptoms, or if you’re simply worried, speak to a doctor without delay. Early diagnosis and treatment of metabolic conditions can improve outcomes and support your child’s development.
By taking a methodical, informed approach—and partnering with trusted medical professionals—you can ensure your toddler receives the evaluation and support they need to reach their walking milestone and beyond.
(References)
* Kishnani PS, Rockman-Greenberg C, Rauch F, Bhatti MT, Moseley S, Denker AE, Watsky E, Whyte MP. Five-year efficacy and safety of asfotase alfa therapy for adults and adolescents with hypophosphatasia. Bone. 2019 Apr;121:149-162. doi: 10.1016/j.bone.2018.12.011. Epub 2018 Dec 18. PMID: 30576866.
* Bonaca MP, Hamburg NM, Creager MA. Contemporary Medical Management of Peripheral Artery Disease. Circ Res. 2021 Jun 11;128(12):1868-1884. doi: 10.1161/CIRCRESAHA.121.318258. Epub 2021 Jun 10. PMID: 34110910.
* Engeroff T, Groneberg DA, Wilke J. After Dinner Rest a While, After Supper Walk a Mile? A Systematic Review with Meta-analysis on the Acute Postprandial Glycemic Response to Exercise Before and After Meal Ingestion in Healthy Subjects and Patients with Impaired Glucose Tolerance. Sports Med. 2023 Apr;53(4):849-869. doi: 10.1007/s40279-022-01808-7. Epub 2023 Jan 30. PMID: 36715875; PMCID: PMC10036272.
* B Aledi L, Flumignan CD, Trevisani VF, Miranda F Jr. Interventions for motor rehabilitation in people with transtibial amputation due to peripheral arterial disease or diabetes. Cochrane Database Syst Rev. 2023 Jun 5;6(6):CD013711. doi: 10.1002/14651858.CD013711.pub2. Epub 2023 Jun 5. PMID: 37276273; PMCID: PMC10240563.
* Ungvari Z, Fazekas-Pongor V, Csiszar A, Kunutsor SK. The multifaceted benefits of walking for healthy aging: from Blue Zones to molecular mechanisms. Geroscience. 2023 Dec;45(6):3211-3239. doi: 10.1007/s11357-023-00873-8. Epub 2023 Jul 26. PMID: 37495893; PMCID: PMC10643563.
* Dhali B, Chatterjee S, Sundar Das S, Cruz MD. Effect of Yoga and Walking on Glycemic Control for the Management of Type 2 Diabetes: A Systematic Review and Meta-analysis. J ASEAN Fed Endocr Soc. 2023;38(2):113-122. doi: 10.15605/jafes.038.02.20. Epub 2023 Sep 19. PMID: 38045671; PMCID: PMC10692414.
* Karstoft K, Thorsen Ik, Nielsen Js, Solomon TPJ, Masuki S, Nose H, Ried-Larsen M. Health benefits of interval walking training. Appl Physiol Nutr Metab. 2024 Jul 1;49(7):1002-1007. doi: 10.1139/apnm-2023-0595. Epub 2024 Mar 20. PMID: 38507778.
* Pasa C, Pamungkasari EP, Doewes M, Purwanto B, Hartono H, Cilmiaty R, Dirgahayu P. Effect of walking and bone joint exercise on enhancing bone remodeling in menopausal women: A randomized controlled trial. Narra J. 2024 Dec;4(3):e1321. doi: 10.52225/narra.v4i3.1321. Epub 2024 Oct 31. PMID: 39816092; PMCID: PMC11731952.
* Bonaca MP, Catarig AM, Houlind K, Ludvik B, Nordanstig J, Ramesh CK, Rasouli N, Sourij H, Videmark A, Verma S, STRIDE Trial Investigators. Semaglutide and walking capacity in people with symptomatic peripheral artery disease and type 2 diabetes (STRIDE): a phase 3b, double-blind, randomised, placebo-controlled trial. Lancet. 2025 May 3;405(10489):1580-1593. doi: 10.1016/S0140-6736(25)00509-4. Epub 2025 Mar 29. PMID: 40169145.
* Rasouli N, Guder Arslan E, Catarig AM, Houlind K, Ludvik B, Nordanstig J, Sourij H, Thomas S, Verma S, Bonaca MP. Benefit of Semaglutide in Symptomatic Peripheral Artery Disease by Baseline Type 2 Diabetes Characteristics: Insights From STRIDE, a Randomized, Placebo-Controlled, Double-Blind Trial. Diabetes Care. 2025 Sep 1;48(9):1529-1535. doi: 10.2337/dc25-1082. PMID: 40543068; PMCID: PMC12368379.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.